FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $571,138 | -46.5% | 119,987 | -36.0% | 0.00% | -33.3% |
| Q1 2023 | $1,068,095 | +11.9% | 187,385 | +98.1% | 0.00% | 0.0% |
| Q4 2022 | $954,575 | -46.0% | 94,606 | +19.9% | 0.00% | -50.0% |
| Q3 2022 | $1,769,000 | -13.7% | 78,917 | -4.7% | 0.01% | +20.0% |
| Q2 2022 | $2,051,000 | -51.3% | 82,787 | -23.8% | 0.01% | -44.4% |
| Q1 2022 | $4,214,000 | -33.7% | 108,700 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $6,360,000 | +4.7% | 108,700 | +6.0% | 0.01% | -7.7% |
| Q3 2021 | $6,075,000 | -34.2% | 102,500 | -3.6% | 0.01% | -31.6% |
| Q2 2021 | $9,228,000 | +5.0% | 106,329 | -0.3% | 0.02% | 0.0% |
| Q1 2021 | $8,789,000 | -7.2% | 106,600 | +2.4% | 0.02% | -13.6% |
| Q4 2020 | $9,466,000 | +135.6% | 104,100 | +3.6% | 0.02% | +120.0% |
| Q3 2020 | $4,017,000 | +16.5% | 100,500 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $3,448,000 | +65.8% | 100,500 | +7.4% | 0.01% | +42.9% |
| Q1 2020 | $2,079,000 | +19.3% | 93,600 | +5.2% | 0.01% | +75.0% |
| Q4 2019 | $1,742,000 | +26.0% | 89,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,382,000 | -23.5% | 89,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $1,807,000 | +18.2% | 89,000 | +2.3% | 0.01% | +25.0% |
| Q1 2019 | $1,529,000 | +129.6% | 87,000 | +67.6% | 0.00% | +100.0% |
| Q4 2018 | $666,000 | -19.2% | 51,900 | +2.6% | 0.00% | 0.0% |
| Q3 2018 | $824,000 | +43.6% | 50,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $574,000 | +95.9% | 50,600 | +68.7% | 0.00% | +100.0% |
| Q1 2018 | $293,000 | +60.1% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $183,000 | +53.8% | 30,000 | 0.0% | 0.00% | – |
| Q3 2017 | $119,000 | +22.7% | 30,000 | 0.0% | 0.00% | – |
| Q2 2017 | $97,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |